$PRVCF The Australian team which will be led by Dr. Maher Khaled, the Chief Executive Officer will work closely with Dr. Harry Parekh, PreveCeutical’s Chief Research Officer, to advance the company’s therapeutic pipeline. The office will provide access for regular engagement with commercial partners on other ventures that PreveCeutical is pursuing in the region.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.